across oncology. worldwide€¦ · across oncology. worldwide josep tabernero esmo president esmo...
TRANSCRIPT
ACROSS ONCOLOGY. WORLDWIDE
Josep Tabernero
ESMO President
ESMO SUMMIT MIDDLE EAST
Friday, 6th April 2018
ESMO
ESMO IN A NUTSHELL
Europe’s leading Medical Oncology Society
ESMO is the leading European professional organisation for
medical oncology, working across Europe and around the world to
erase boundaries in cancer care and to provide medical oncology
education within an integrated approach to cancer care
ESMO MISSIONImprove the quality
of prevention, diagnosis, treatment,
supportive and palliative care
Disseminate knowledge in
oncology to cancer patients and the public
Facilitate equal access to optimal cancer care for all
cancer patients
Maintain liaisons with other oncology
specialties, cancer leagues, universities,
patient groups & where appropriate, the
pharmaceutical industry
Advance the art, science, recognition,
and practice of oncology
Promote education in oncology to ensure a
high standard of qualification for medical oncologists within the multidisciplinary team
Educate and train persons involved in clinical cancer care
and research
ESMO 2020 VISION
Securing the best possible outcomes for people with cancer
Membership
ConferencesPublic Policy
Career Development
OncologyProClinical Practice
ESMO MEMBERSHIP AND GLOBAL NETWORK
Membership Distribution
North America
9%
South America 6%
Europe 55%
Africa 5%
Asia-Pacific 25%
As of 31 December 2017
> 18,000 members
Over 150 countries
Reciprocal membership agreements
with 50 national oncology societies
TOOLS AND RESOURCES
OncologyPRO – ESMO’s online education portal
Scientific and educational online portal
Direct access 24/7 to
oncology news, scientific and educational resources
Information by disease-type
Continuously updated
DISSEMINATING CANCER INFORMATION WORLDWIDE
The official journal of ESMO, providing rapid and efficient peer-review publications on innovative cancer treatments, or translational
work related to oncology and precision medicine.
Ranked #10 in Oncology
Over 4.3 million downloads in 2016
Accessed by 3,569 institutions worldwide
Over 2 million unique readers in 188 countries
Over 15,000 followers on Twitter
Official journal of JSMO
ESMO’s online-only, peer-reviewed open access journal, dedicated to publishing high-quality medical research and educational content from all
disciplines of oncology.
Indexing: Google Scholar, PubMed Central, Emerging Sources Citation Index (Web of Science)
Global reach: 241 submissions from 34 countries
Broad coverage: 157 papers published
Affiliations with AIOM, CSCO, KACO, JSMO
SETTING THE STANDARDS OF CARE FOR
CLINICAL CANCER PRACTICE
ESMO Clinical Practice Guidelines
Evidence-based
guidelines to support
clinicians in delivering
patients the best cancer treatment options
Latest information on
diagnostic criteria, disease
staging, risk assessment,
treatment plan and follow-up
Regularly updated and reviewed by
leading oncology experts
More than 70 available from
the ESMO website or the ESMO mobile
app
Approximately 20 patient
friendly versions available
ESMO MEETINGSExchange expertise and knowledge at our first class events
Congresses Symposia Educational Courses
ENSURING ACCESS TO CANCER MEDICINES
A critical issue for medical oncologists
To treat patients according to the ESMO Clinical
Practice Guidelines, medical oncologists need to have
access to the cancer medicines recommended in
the guidelines.
In Europe ESMO works closely with the European Medicines Agency and the
European Network of Health Technology Assessment in
order to harmonise the approval and reimbursement
process for cancer medicines in Europe.
ESMO has conducted international surveys on the
availability of cancer medicines and has proposed recommendations on how to
reduce the barriers.
ESMO keeps its members updated on the latest in personalised medicine, immunotherapies and biosimilars in a rapidly-
advancing landscape of new cancer treatments
ESMO: MEDICAL ONCOLOGY EDUCATION BROUGHT
DIRECTLY TO YOU
A global society with a tailored education offer to meet your local needs
ESMO SUMMIT MIDDLE EAST 2018
Dubai, United Arab Emirates - 06 Apr - 07 Apr 2018
Oncology Updates: From Evidence to Practice
Designed to address the specific challenges faced by oncology professionals practising in this region
Local and international experts covering the cancer types most frequently encountered in Sub-Saharan Africa
Series of clinical case presentations followed by time for discussion
To provide the oncology community with a summary of the most significant treatment advances presented at the ESMO annualcongress
To review the current standard of care for key malignancies from a local and international perspective
To discuss the current controversies in the management of specific cancers
Participants Category
Faculty 32
Delegates 263
ESMO Staff 3
Total 298
ESMO SUMMIT MIDDLE EAST 2018
Participants Overview
UAE 55%
Iraq 18%
Lebanon 7,3%
Saudi Arabia 4,7%
ESMO SUMMIT MIDDLE EAST 2018
Country break down (Delegates: 250+) Country DelegateAustralia 1Canada 1Czech Republic 1China 3Egypt 6France 1Germany 1Hungary 1India 1Iran 3Iraq 42Jordan 6Korea 1Saudi Arabia 12Kuwait 2Lebanon 17Netherlands 1Philippines 6Syria 1UAE 156Total 263